Once-daily BREO is a prescription medicine for adults with asthma who need both an ICS (inhaled corticosteroid) and a LABA (long-acting beta2-adrenergic agonist) medicine. BREO is not for people whose asthma is well controlled on an asthma control medicine, like an ICS. BREO is not used to relieve sudden breathing problems and won’t replace a rescue inhaler.
BREO is the first and only once-daily inhaled asthma combination treatment—an inhaled corticosteroid (fluticasone furoate) and a long-acting beta2-adrenergic agonist (vilanterol)—that has been shown to work all day and night, for a full 24 hours. It opens up airways in the lungs for better breathing. Your results may vary.
BREO prevents symptoms such as wheezing, cough, chest tightness, and shortness of breath and can help keep them from coming back. Your results may vary.
Taking once-daily BREO every day can also reduce the days when asthma symptoms occur and reduce the days when a rescue inhaler is needed. Your results may vary.
BREO is not a rescue medicine and should not be used to treat sudden symptoms of asthma.
Two of the main causes of asthma symptoms are airway inflammation and airway constriction. BREO treats these two causes with a combination of two medicines:
In people with a history of asthma flare-ups (or "exacerbations"), BREO has been shown to reduce the risk of future flare-ups. A flare-up is a time when asthma symptoms have worsened and are severe enough to require treatment with steroids, or also a hospital stay or emergency department visit. Your results may vary.